Mostrando 10 resultados de: 10
Filtros aplicados
Publisher
Cancer Biology and Therapy(4)
Clinical Cancer Research(1)
Frontiers in Public Health(1)
Nuclear Medicine Communications(1)
Revista Cubana de Cirugia(1)
Área temáticas
Enfermedades(10)
Farmacología y terapéutica(6)
Cirugía y especialidades médicas afines(2)
Medicina y salud(2)
Problemas sociales y servicios a grupos(2)
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(10)
ODS 3: Salud y bienestar(10)
ODS 17: Alianzas para lograr los objetivos(5)
ODS 9: Industria, innovación e infraestructura(3)
ODS 5: Igualdad de género(1)
Origen
scopus(10)
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
ArticleAbstract: Purpose: EGFR is a well-validated target for patients with non-small cell lung cancer (NSCLC). CIMAvPalabras claves:Autores:Acosta S.C., Aguilera N., Alonso L., Amador R.M., Arzuaga L., Cala M., Carmen Elena Viada, Catala M., Crespo T., De La Torre A.V., Fleytas R., Flores Y.I., Futiel N., García Verdecia B., Lage Davila A., Luaces P.L.o., Marrero Miragaya M.A., Martínez O., Mazorra Z., Mendoza S., Neninger Vinageras E., Otero Y., Parra J., Pomares Y., Popa X., Reyes D., Rodríguez G., Rodríguez P.C., Romero G.N., Sabates T., Santiesteban E.R., Sierra P., Tania Crombet, Vello L.Fuentes:scopusA pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer
ArticleAbstract: Nimotuzumab is a humanized IgG1 monoclonal antibody against the EGFR extracellular domain that has bPalabras claves:Advanced cervical cancer, eGFR, Monoclonal antibody, nimotuzumab, Pilot studyAutores:Astudillo H., Avila S., Bazán B., Bojalil R., Cetina L., Charco E., Coronel J., Dueñas-Gonzãlez A., Jiménez-Lima R., Ramos M., Tania Crombet, Zapata S.Fuentes:scopusSystemic and skin toxicity in Cercopithecus aethiops sabaeus monkeys treated during 26 weeks with a high intravenous dose of the anti-epidermal growth factor receptor monoclonal antibody nimotuzumab
ArticleAbstract: Nimotuzumab (h-R3) is a humanized anti-epidermal growth factor receptor monoclonal antibody (mAb) rePalabras claves:animal model, CETUXIMAB, Epidermal growth factor receptor, General toxicity, H-R3, Monkeys, nimotuzumab, Skin toxicityAutores:Arteaga M.E., Ballester-Labrada A., Baro F., Boleda M., Casacó Parada A.R., Charro L., Fuentes D., García M., González B., González C., Hernández O., Ledón N., Macías A.E., Morales Y., Orphee R., Pardo B., Pérez A., Ramos M., Rodríguez V., Rodriquez L., Subirós N., Tania Crombet, Viña L.Fuentes:scopusMortality from malignant brain tumors within the first 30 days after surgery
ArticleAbstract: Introduction: The neurological complications found in the high gradegliomas surgery are primarily rePalabras claves:Malignant gliomas, Mortality , Surgical resection gradeAutores:Domínguez W., Pila Bandera M., Roig Fabre E., Solomón M.T.e., Tania CrombetFuentes:scopusNimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario
ArticleAbstract: EGFR signaling is an important regulator of SARS-CoV induced lung damage, inflammation and fibrosis.Palabras claves:brief research report nimotuzumab, covid-19, eGFR, FIBROSIS, inflammation, Monoclonal antibody, SARS-COV-2Autores:Batista D., Cabrera L., Diaz H., Domeq M., Gorte A., Hernández A., Hernández R., Jiménez J., Jova J.H., Luaces P.L.o., Martínez A., Medel L., Pérez Ruiz L., Porto L., Ramos M., Saavedra Hernández D., Sánchez L., Tania Crombet, Travieso N., Troche M., Valdés L., Valls A.R.Fuentes:scopusNimotuzumab in combination with radiotherapy in high grade glioma patients: A single institution experience
ArticleAbstract: Nimotuzumab, a humanized antibody targeting epidermal growth factor receptor, has potent anti-prolifPalabras claves:Anaplastic astrocytoma, glioblastoma multiforme, High grade glioma, Monoclonal antibody, nimotuzumab, RadiotherapyAutores:Alert J., Chon I., Jorrín E., Luaces P.L.o., Marinello J.J.u., Miranda N., Solomón M.T.e., Tania CrombetFuentes:scopusTreatment of malignant, non-resectable, epithelial origin esophageal tumors with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy
ArticleAbstract: Overexpression of epidermal growth factor receptor in esophageal cancer is associated with poor progPalabras claves:Chemorariotherapy, Esophageal cancer, Humanized monoclonal, nimotuzumabAutores:Albuerne Y.A., Alert J., Alvarez E.S., Callejo I.P., De La Vega H.A., Gonzalez C.E.V., Gonzalez Y.S., Hernadez I.M., Lazo N.G., Luaces P.L.o., Martell J.A.n., Moreno B.P., Perez M.L., Ramos-Suzarte M., Ruiz-Garcia E.B., Soriano J.L., Tania CrombetFuentes:scopusSerum magnesium levels in oncologic patients treated with nimotuzumab
ArticleAbstract: Introduction: some adverse effects have been reported with the use of monoclonal antibodies againstPalabras claves:Epidermal growth factor receptor, Hypomagnesaemia, Monoclonal antibody, nimotuzumabAutores:Bacallao Méndez R.A., Dávalos Iglesias J.M., Gutiérrez García F., Llerena Ferrer B., Mañalich Comas R., Tania CrombetFuentes:scopusPhase i/ii clinical trial of the humanized anti-egf-r monoclonal antibody h-r3 labelled with <sup>99m</sup>tc in patients with tumour of epithelial origin
ArticleAbstract: To evaluate the biodistribution, internal radiation dosimetry and toxicity of the humanized MAb h-R3Palabras claves:biodistribution, Dosimetry, Humanized MAb, RadioimmunodiagnosisAutores:Aguilar V., Batista J.F., Coca M.A., Hernández A., Iznaga-Escobar N., Neninger Vinageras E., Perera A., Pérez M., Ramos M., Romero S., Sánchez E., Tania Crombet, Torres L.Fuentes:scopusPulmonary Thrombosis in COVID-19 Treated by Thrombolysis: A Small Case Series Using Streptokinase
OtherAbstract:Palabras claves:Autores:Betancourt Cervantes J., Caballero Font J.A., Caballero López A., Chávez González E., González Reinoso D., Herrera Cartaya C., Morales Valdera A., Nápoles Lizano M.E., Sánchez Vera N., Tania Crombet, Vázquez Roque A.Fuentes:scopus